Strategic Lending Horizon specializes in venture debt for life sciences and technology firms with a track record of over $3.5 billion funded since 2004, indicating strong expertise and a ready pipeline for growth-focused financing opportunities.

Growth Financing Recent loan facilities to Hyperfine ($40M), Stellar Cyber ($25M), Bioness Medical ($15M), and Pelthos Therapeutics ($50M) demonstrate active deployment across high-potential VC-backed startups, suggesting ongoing demand for scalable credit facilities to support product expansion and clinical milestones.

Portfolio Synergy Horizon maintains deep venture community relationships and operates as a bridge lender, which positions it as a strategic partner for portfolio companies seeking additional capital cycles or risk-tolerant debt solutions aligned with growth trajectories.

Geographic Reach Headquartered in Connecticut with a Californian regional office and nationwide investment professionals, Horizon can connect buyers across tech hubs, enabling cross-market deal flow and regional coverage for emerging life science and tech companies.

Affiliates & Partnerships Affiliation with Monroe Capital and collaboration with finance partners like Roth Capital and CR Financial indicate an established syndication network, offering co-lending and fundraising leverage to potential clients seeking flexible capital structures.